Dr. Mui obtained her B.Sc. and PhD from UBC before pursuing post-doctoral studies at Merck’s DNAX Research Institute in Palo Alto, California. Her UBC research lab is located at Vancouver General Hospital campus where she studies the intracellular regulatory pathways which control immune cell function. These studies have led to development of anti-inflammatory and anti-cancer drugs which are currently being tested in human clinical trials by a spin-off company that she helped found.